DULOXETINE AGH 30 duloxetine (as hydrochloride) 30 mg enteric capsule blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

duloxetine hydrochloride, Quantity: 33.65 mg

Disponible desde:

Alembic Pharmaceuticals Australia Pty Ltd

Designación común internacional (DCI):

Duloxetine hydrochloride

formulario farmacéutico:

Capsule, enteric

Composición:

Excipient Ingredients: hypromellose phthalate; triethyl citrate; indigo carmine; purified talc; hypromellose; Gelatin; titanium dioxide; sucrose; maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; iron oxide yellow; Shellac; strong ammonia solution

Vía de administración:

Oral

Unidades en paquete:

28 capsules

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Duloxetine capsules are indicated for the treatment of major depressive disorder (MDD).,Treatment of Diabetic Peripheral Neuropathic Pain (DPNP). Treatment of Generalised Anxiety Disorder (GAD).

Resumen del producto:

Visual Identification: Opaque blue/white hard gelatin capsule '157' on body and 'A' on cap with green ink; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius

Estado de Autorización:

Licence status A

Fecha de autorización:

2013-06-14